Abivax (AAVXF) Interest & Investment Income (2024 - 2026)

Abivax has reported Interest & Investment Income for 3 years, with the latest figure at $14.9 million in Q1 2026.

• On a quarterly basis, Interest & Investment Income rose 815.0% year-over-year to $14.9 million in Q1 2026; TTM through Mar 2026 was $48.3 million, a 262.41% increase from a year earlier, with the FY2025 full-year figure at $32.1 million, up 118.51% from the prior year.
• Interest & Investment Income was $14.9 million for Q1 2026 at Abivax, up from $5.6 million in the prior quarter.
• The five-year high for Interest & Investment Income was $23.9 million in Q3 2025, with the low at $1.6 million in Q1 2025.
• Average Interest & Investment Income over 3 years is $7.6 million, with a median of $4.0 million recorded in 2024.
• The sharpest annual moves came in 2025 and 2026: Interest & Investment Income sank 75.08% in 2025, then surged 815.0% in 2026.
• Over 3 years, Interest & Investment Income stood at $4.0 million in 2024, then soared by 38.27% to $5.6 million in 2025, then jumped by 167.23% to $14.9 million in 2026.
• The last three Interest & Investment Income figures came in at $14.9 million (Q1 2026), $5.6 million (Q4 2025), and $23.9 million (Q3 2025), per Business Quant data.